Lipsitch Marc, Sousa Alexandra O
Departments of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Genetics. 2002 Aug;161(4):1599-607. doi: 10.1093/genetics/161.4.1599.
Infections have long been thought to exert natural selection on humans. Infectious disease resistance is frequently invoked as a mechanism shaping human genetic diversity, but such hypotheses have rarely been quantitatively evaluated with direct measures of disease-related mortality. Enhancement of genetically determined resistance to tuberculosis by natural selection has been proposed as a factor explaining the decline of tuberculosis in Europe and North America in the period 1830-1950 (before the advent of antimicrobial chemotherapy) and the apparently reduced susceptibility of Europeans and their descendants to tuberculosis infection and/or disease. We used Swedish vital statistics from 1891 to 1900 to estimate that individuals who escaped mortality from pulmonary tuberculosis (PTB) during the European tuberculosis epidemic would have enjoyed a fitness advantage of 7-15% per generation compared to individuals who were susceptible to PTB mortality; individuals with 50% protection would have had a selection coefficient of 4-7%/generation. Selection during the peak of the European TB epidemic could have substantially reduced the frequency of already rare alleles conferring increased susceptibility to PTB mortality, but only if the phenotypic effects of these alleles were very large. However, if resistant alleles were rare at the beginning of this period, 300 years would not have been long enough for such selection to increase their frequency to epidemiologically significant levels. Reductions in the frequency of rare susceptibility alleles could have played at most a small part in the decline of the epidemic in the century preceding 1950. Natural selection by PTB deaths during the European TB epidemic alone cannot account for the presently low level of TB disease observed among Europeans and their descendants just prior to the appearance of antibiotic treatment.
长期以来,人们一直认为感染对人类施加自然选择。传染病抗性常被视为塑造人类遗传多样性的一种机制,但这类假说很少通过与疾病相关死亡率的直接测量进行定量评估。有人提出,自然选择增强了对结核病的遗传抗性,这是解释1830年至1950年期间(在抗菌化疗出现之前)欧洲和北美结核病发病率下降以及欧洲人及其后裔对结核病感染和/或疾病易感性明显降低的一个因素。我们利用1891年至1900年瑞典的人口统计数据估计,在欧洲结核病流行期间从肺结核(PTB)死亡中逃脱的个体,与易患PTB死亡的个体相比,每代享有7%至15%的适应性优势;具有50%保护作用的个体的选择系数为4%至7%/代。欧洲结核病流行高峰期的选择可能大幅降低了已经罕见的、赋予PTB死亡易感性增加的等位基因的频率,但前提是这些等位基因的表型效应非常大。然而,如果抗性等位基因在这一时期开始时就很罕见,300年的时间不足以让这种选择将其频率提高到具有流行病学意义的水平。在1950年之前的一个世纪里,罕见易感性等位基因频率的降低最多只能在疫情下降中起到很小的作用。仅欧洲结核病流行期间PTB死亡导致的自然选择无法解释在抗生素治疗出现之前欧洲人及其后裔中目前观察到的低水平结核病。